Adagene to Present at Leerink’s Global Healthcare Conference 2025

SAN DIEGO and SUZHOU, China, March 06, 2025 (GLOBE NEWSWIRE) — Adagene Inc. (“Adagene”) (NASDAQ:ADAG), a company transforming the discovery and development of novel antibody-based therapies, today announced that Adagene’s Chairman, Chief Executive Officer and President of R&D, Peter Luo, Ph.D., will participate in one-on-one investor meetings and provide a corporate update at Leerink’s Global Healthcare Conference 2025, taking place March 10-12 in Miami, Florida.

Leerink’s Global Healthcare Conference 2025

• Presentation Date: Wednesday, March 12
• Presentation Time: 10:40-11:20 AM (Eastern Time)
• Location: W South Beach

A webcast of the presentation will be accessible in the Investors section of the company’s website at https://www.adagene.com for at least 30 days.

About Adagene

Full story available on Benzinga.com